Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?

The tax politics of the Medtronic deal

Medtromic's 'Rising Man' symbol
The "Rising Man" symbol stands in front of the Fridley, Minn., based Medtronic.
Jim Mone/Associated Press

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

The deal to buy Irish medical device manufacturer Covidien would effectively make Fridley-based Medtronic a foreign company. That would lower Medtronic's taxes and offer it access to it's own overseas cash without paying U.S. taxes.

As Steven Davidoff reported in The New York Times Monday, the deal is carefully written to allow Medtronic to pull out if Congress changes the laws around the "inversion tax loophole" that makes the deal so potentially lucrative.

Is Congress actually close to doing that? Davidoff joins The Daily Circuit to talk about the loophole and the political effort to close it.